When did Tandem Diabetes Care report Q4 2024 earnings?

Tandem Diabetes Care (TNDM) reported Q4 2024 earnings on February 26, 2025 after market close.

What were Tandem Diabetes Care's Q4 2024 revenue and EPS?

Tandem Diabetes Care reported revenue of $282.6M and eps of $-0.44 for Q4 2024.

Did Tandem Diabetes Care beat estimates in Q4 2024?

Revenue beat the consensus estimate of $251.4M by $31.3M. EPS missed the consensus estimate of $-0.25 by $0.19.

Where can I find Tandem Diabetes Care's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001438133-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.

Tandem Diabetes Care TNDM Q4 2024 Annual earnings

Reported February 26, 2025 · After market close

Revenue$282.6MBeat by $31.3M

EPS-$0.44Miss by $0.19

Revenue estimate$251.4M

EPS estimate-$0.25

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$255.0M

EPS estimate-$0.34

Financials

Q4 2024

Income statement

See full

Revenue$282.6M+43.6%

Gross profit$157.5M+68.8%

Operating income-$581.0K+98.3%

Net income$755.0K+103%

EPS (diluted)$0.01+102%

Balance sheet

See full

Cash & equivalents$69.2M+17.6%

Total debt$514.2M+23.7%

Total equity$263.1M-16.1%

Total assets$967.7M+1.6%

Cash flow

See full

Operating cash flow$10.7M+249%

CapEx$3.1M-41.0%

Free cash flow$7.6M+162%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.37B+22.6%

Enterprise value$2.81B+23.0%

P/S2.5×-0.1×

Profitability

See full

Gross margin52.1%+2.9pp

Operating margin-10.5%-4.2pp

Net margin-10.2%-4.0pp

FCF margin0.5%+0.3pp

Returns & leverage

See full

Return on equity-33.3%-10.1pp

Debt / equity2×+0.6×

Current ratio2.9×-0.9×

Segments

By product

See full

Supplies and other$128.2M+8.8%

Pump$124.2M+35.9%

By geography

See full

United States$214.6M+42.2%

Versus estimates

Revenue

Q1 2026$247.2MBeat by $6.8M Q4 2025$290.4MBeat by $13.4M Q3 2025$249.3MMiss by $27.7M Q2 2025$240.7MMiss by $9.5M Q1 2025$234.4MBeat by $14.2M

Q4 2024$282.6MBeat by $31.3M

Diluted EPS

Q1 2026-$0.30Beat by $0.16 Q4 2025-$0.01Beat by $0.04 Q3 2025-$0.31In line Q2 2025-$0.48Miss by $0.08 Q1 2025-$0.67Miss by $0.07

Q4 2024-$0.44Miss by $0.19

Ask the moment Tandem Diabetes Care reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Tandem Diabetes Care report Q4 2024 earnings?: Tandem Diabetes Care (TNDM) reported Q4 2024 earnings on February 26, 2025 after market close.
What were Tandem Diabetes Care's Q4 2024 revenue and EPS?: Tandem Diabetes Care reported revenue of $282.6M and eps of $-0.44 for Q4 2024.
Did Tandem Diabetes Care beat estimates in Q4 2024?: Revenue beat the consensus estimate of $251.4M by $31.3M. EPS missed the consensus estimate of $-0.25 by $0.19.
Where can I find Tandem Diabetes Care's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001438133-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.